Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Phasebio Pharmaceuticals Inc (PHAS)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1. 360,542 $1,503 +81% 0.56%
2.
Sabby Capital

Hal Mintz

124,788 $520 +51% 0.28%
3.
Rock Springs Capital Management

Kris Jenner, Gordon Bussard, Graham Mcphail

1,416,900 $5,908 -1% 0.23%
4. 816,448 $3,405 0.2%
5.
Sectoral Asset Management

Jerome Pfund And Michael Sjostrom

196,000 $817 +12% 0.14%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$3.94 1,000 Officer 7,600 2018-12-13 Filing
$4.46 1,000 Director 1,000 2018-12-17 Filing
$3.69 1,000 Officer, Director 51,199 2018-12-13 Filing
$3.85 800 Officer, Director 50,199 2018-12-10 Filing
$3.89 700 Officer, Director 49,399 2018-12-07 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$14.00 459 Large Shareholder, Director 415,959 2019-07-01 Filing
$14.00 255 Large Shareholder, Director 52,397 2019-07-01 Filing
$14.00 180 Large Shareholder, Director 162,890 2019-07-01 Filing
$14.00 2,014 Large Shareholder, Director 1,818,638 2019-07-01 Filing
$14.00 63 Large Shareholder, Director 416,418 2019-06-18 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 34,208 $143 0.05%
2. 17,919 $75 0.03%
3. 21,738 $91 0.01%
4. 20,000 $83 0.01%
5. 203,458 $844 0%